Database Query Results : , , Cyc
Cyc, Cyclin: Click to Expand ⟱
| Source: |
| Type: |
Cyclins are indispensable elements of the cell cycle and derangement of their function can lead to cancer formation.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
Liver, |
FaO |
|
|
|
Cyc↓, P21↑, ROS↑, p‑P53↑, BAX↑, Cyt‑c↑, Casp↑, survivin↓, JNK↑, Akt↓,
Bcl-2↓, survivin↓, Casp8↑, P53↑, Sharpin↓, APAF1↑, p‑Akt↓, NF-kB↓, P21↑, Cyc↓, CDK2↓, CDK4/6↓, Snail↓, ChemoSen↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
Cyc↓, CycB/CCNB1↓, CDK1↓, P21↑, PCNA↝, HDAC↓,
CDK1↓, Cyc↓, p27↑, P21↑, P53↑, TumCCA↑, TumCI↓, MMP2↓, MMP9↓, E-cadherin↑, N-cadherin↓, Vim↓, LC3A↑, p62↓, p‑mTOR↓, PD-L1↓, CAFs/TAFs↓, VEGF↓, ROCK1↓, Bcl-2↓, Bcl-xL↓, BAX↑, ROS↑, cl‑PARP↑, Casp3↑, Casp9↑, PTEN↑, MMP↓, Cyt‑c↑, Ca+2↑, PERK↑, IRE1↑, CHOP↑, Copper↑, Snail↓, Vim↓, Twist↓, GSH↓, NRF2↓, HO-1↓, GPx4↓, XIAP↓, survivin↓, DR5↑,
| - |
in-vitro, |
neuroblastoma, |
NA |
|
|
|
CSCs↓, CD133↓, β-catenin/ZEB1↓, n-MYC↓, SOX2↓, NOTCH2↓, Nestin↓, TumCCA↑, TumCP↓, CDK1↓, Cyc↓, Apoptosis↑, Bax:Bcl2↑, NCAM↓, MMP2↓, MMP9↓, *Smad1↑, *HSP70/HSPA5↑, *LAMs↑,
TumCP↓, Cyc↓, TOP1↓, TumCCA↑, angioG↓, NF-kB↓, Sp1/3/4↓, VEGF↓, MMPs↓, ChemoSen↑, eff↑, MMP↓, ROS↑, Bcl-2↓, Bcl-xL↓, Mcl-1↓, lipid-P↑, RadioS↑, eff↑,
NAD↝, SAM-e↝, PSA↓, IGF-1↓, Cyc↓, P21↓, p‑MEK↓, p‑ERK↓, ROS↑, SOD↓, Catalase↓, MDA↑, GSH↓, IL1↓, IL6↓, TNF-α↓, BRAF↝, MAPK↝, PTEN↝, PI3K/Akt↝, eIF2α↑, ATF4↑, ATF6↑, NRF2↑, BAX↑, BID↑, Casp3↑, Casp9↑, Bcl-2↓, Bcl-xL↓,
Cyc↓, MAPK↓, TumCMig↓, LAMP2↓, p‑ERK⇅, TumCM/A↑,
*hs-CRP↓, *TNF-α↓, *SOD↑, *Catalase↑, *GPx↑, *cognitive↑, *memory↑, *Risk↓, *SAM-e↑, *NAD↝, *ATP↝, *Ca+2↝, HDAC↓, TumVol↓, IGF-1↓, PSA↓, Cyc↓, TumCMig↓, *serineP↓, HIF-1↓, *ChemoSideEff↓, *VitD↑, *Mag↑, *eff↑, Risk↓, *Inflam↓, *neuroP↑, *Calcium↑, *BMD↑, *chemoP↑, AntiCan↑, *Dose↑, *Dose↝, *BMPs↑, *testos↑, angioG↓, Apoptosis↑, *selectivity↑, *chemoPv↑,
NF-kB↝, Akt↝, AR↝, Apoptosis↝, Bcl-2↝, Casp3↝, BAX↝, P21↝, ROS↝, Apoptosis↝, Bcl-xL↝, JNK↝, MMP2↝, P53↝, PSA↝, VEGF↝, COX2↝, cycD1/CCND1↝, EGFR↝, IL6↝, β-catenin/ZEB1↝, mTOR↝, NRF2↝, p‑Akt↝, AP-1↝, Cyt‑c↝, PI3K↝, PTEN↝, Cyc↝, TNF-α↝,
| - |
in-vitro, |
NMSC, |
A431 |
|
|
|
- |
in-vitro, |
NMSC, |
UW-BCC1 |
|
|
|
- |
in-vitro, |
Nor, |
NHEKn |
|
|
|
TumCG↓, TumCCA↑, Cyc↓, Apoptosis↑, cl‑Casp3↑, cl‑Casp8↑, cl‑PARP↑, HH↓, Smo↓, Gli1↓, GLI2↓, Shh↓, Sufu↑, BAX↑, Bcl-2↓, *toxicity↓,
*BioAv↓, Inflam↓, COX2↓, TumCCA↑, ChemoSen↑, RadioS↑, selectivity↑, ROS↑, DNAdam↑, antiOx↑, SOD↑, Catalase↑, GPx↑, GSH↑, NRF2↑, NF-kB↓, Cyc↓, CDK1↑, P21↑, p27↑, P53↑, VEGF↓, MAPK↓,
| - |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
NA, |
AD, |
NA |
|
|
|
- |
in-vitro, |
GBM, |
A172 |
|
|
|
- |
in-vitro, |
GBM, |
T98G |
|
|
|
Warburg↓, OCR↑, lactateProd↓, TumCP↓, TumCCA↑, AMPK↑, ACC↓, Cyc↓, neuroP↑, Cyt‑c↝, Glycolysis↓, ECAR↓, TumCG↓, other↓,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 13
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, Catalase↓, 1, Catalase↑, 1, Copper↑, 1, GPx↑, 1, GPx4↓, 1, GSH↓, 2, GSH↑, 1, HO-1↓, 1, lipid-P↑, 1, MDA↑, 1, NRF2↓, 1, NRF2↑, 2, NRF2↝, 1, ROS↑, 5, ROS↝, 1, SAM-e↝, 1, SOD↓, 1, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
p‑MEK↓, 1, MMP↓, 2, OCR↑, 1, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
ACC↓, 1, AMPK↑, 1, ECAR↓, 1, Glycolysis↓, 1, lactateProd↓, 1, NAD↝, 1, PI3K/Akt↝, 1, TumCM/A↑, 1, Warburg↓, 1,
Cell Death ⓘ
Akt↓, 1, Akt↝, 1, p‑Akt↓, 1, p‑Akt↝, 1, APAF1↑, 1, Apoptosis↑, 3, Apoptosis↝, 2, BAX↑, 4, BAX↝, 1, Bax:Bcl2↑, 1, Bcl-2↓, 5, Bcl-2↝, 1, Bcl-xL↓, 3, Bcl-xL↝, 1, BID↑, 1, Casp↑, 1, Casp3↑, 2, Casp3↝, 1, cl‑Casp3↑, 1, Casp8↑, 1, cl‑Casp8↑, 1, Casp9↑, 2, Cyt‑c↑, 2, Cyt‑c↝, 2, DR5↑, 1, JNK↑, 1, JNK↝, 1, MAPK↓, 2, MAPK↝, 1, Mcl-1↓, 1, p27↑, 2, survivin↓, 3,
Kinase & Signal Transduction ⓘ
Sp1/3/4↓, 1,
Transcription & Epigenetics ⓘ
other↓, 1,
Protein Folding & ER Stress ⓘ
ATF6↑, 1, CHOP↑, 1, eIF2α↑, 1, IRE1↑, 1, PERK↑, 1,
Autophagy & Lysosomes ⓘ
LAMP2↓, 1, LC3A↑, 1, p62↓, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 3, P53↝, 1, p‑P53↑, 1, cl‑PARP↑, 2, PCNA↝, 1,
Cell Cycle & Senescence Cycle, Senescence & Post-Mitotic Control group encompasses regulation of cell division, checkpoint enforcement, cellular senescence, and aberrant cell-cycle re-entry in post-mitotic cells. It is critical for cancer proliferation contro" style="cursor:help;color:#555;font-weight:normal;">ⓘ
CDK1↓, 3, CDK1↑, 1, CDK2↓, 1, Cyc↓, 12, Cyc↝, 1, CycB/CCNB1↓, 1, cycD1/CCND1↝, 1, P21↓, 1, P21↑, 5, P21↝, 1, TumCCA↑, 6,
Proliferation, Differentiation & Cell State ⓘ
BRAF↝, 1, CD133↓, 1, CSCs↓, 1, p‑ERK↓, 1, p‑ERK⇅, 1, Gli1↓, 1, HDAC↓, 2, HH↓, 1, IGF-1↓, 2, mTOR↝, 1, p‑mTOR↓, 1, n-MYC↓, 1, Nestin↓, 1, NOTCH2↓, 1, PI3K↝, 1, PTEN↑, 1, PTEN↝, 2, Shh↓, 1, Smo↓, 1, SOX2↓, 1, Sufu↑, 1, TOP1↓, 1, TumCG↓, 2,
Migration ⓘ
AP-1↝, 1, Ca+2↑, 1, CAFs/TAFs↓, 1, CDK4/6↓, 1, E-cadherin↑, 1, GLI2↓, 1, MMP2↓, 2, MMP2↝, 1, MMP9↓, 2, MMPs↓, 1, N-cadherin↓, 1, NCAM↓, 1, ROCK1↓, 1, Sharpin↓, 1, Snail↓, 2, TumCI↓, 1, TumCMig↓, 2, TumCP↓, 3, Twist↓, 1, Vim↓, 2, β-catenin/ZEB1↓, 1, β-catenin/ZEB1↝, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 2, ATF4↑, 1, EGFR↝, 1, HIF-1↓, 1, VEGF↓, 3, VEGF↝, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, COX2↝, 1, IL1↓, 1, IL6↓, 1, IL6↝, 1, Inflam↓, 1, NF-kB↓, 3, NF-kB↝, 1, PD-L1↓, 1, PSA↓, 2, PSA↝, 1, TNF-α↓, 1, TNF-α↝, 1,
Hormonal & Nuclear Receptors ⓘ
AR↝, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 3, eff↑, 2, RadioS↑, 2, selectivity↑, 1,
Clinical Biomarkers ⓘ
AR↝, 1, BRAF↝, 1, EGFR↝, 1, IL6↓, 1, IL6↝, 1, PD-L1↓, 1, PSA↓, 2, PSA↝, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, neuroP↑, 1, Risk↓, 1, TumVol↓, 1,
Total Targets: 172
Pathway results for Effect on Normal Cells:
NA, unassigned ⓘ
chemoPv↑, 1,
Redox & Oxidative Stress ⓘ
Catalase↑, 1, GPx↑, 1, SAM-e↑, 1, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↝, 1,
Core Metabolism/Glycolysis ⓘ
NAD↝, 1,
Protein Folding & ER Stress ⓘ
HSP70/HSPA5↑, 1,
Migration ⓘ
Ca+2↝, 1, LAMs↑, 1, serineP↓, 1, Smad1↑, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1, TNF-α↓, 1, VitD↑, 1,
Hormonal & Nuclear Receptors ⓘ
testos↑, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, Dose↑, 1, Dose↝, 1, eff↑, 1, selectivity↑, 1,
Clinical Biomarkers ⓘ
BMD↑, 1, BMPs↑, 1, Calcium↑, 1, hs-CRP↓, 1, Mag↑, 1, VitD↑, 1,
Functional Outcomes ⓘ
chemoP↑, 1, ChemoSideEff↓, 1, cognitive↑, 1, memory↑, 1, neuroP↑, 1, Risk↓, 1, toxicity↓, 1,
Total Targets: 34
Scientific Paper Hit Count for: Cyc, Cyclin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:374 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page